Revenue Beats, But Margins Miss—Again
Q2 revenue grew 15% YoY to ₹758 Cr, but manufacturing EBITDA landed at ₹4.6 per litre—well below the 5–7 per litre guidance—and R&O margins fell 160 basis points. Management reaffirmed guidance anyway, raising execution questions.
₹758 Cr
+15% YoY
₹4.6
vs ₹5–7 guidance
16%
−160 bps YoY
₹0.2 Cr
Narrowed; near breakeven
On the headline, Globus Spirits delivered exactly what the street wanted: revenue up 15% to ₹758 crore, driven by manufacturing, regular & others (R&O), and prestige & above (P&A) all tracking forward. But flip to operational margins—the real story—and the quarter cracks. Manufacturing EBITDA came in at ₹4.6 per litre, well below the mid-point of management's 5–7 per litre guidance band. R&O segment margins fell 160 basis points year-on-year, pressured by raw material inflation, packaging costs, and the sequentially lower volumes from Rajasthan. Management blamed seasonality (Q2 typically weak), commodity volatility (maize and broken rice FCI allocation), and the ongoing Uttar Pradesh ramp. Then they reaffirmed both guidance bands anyway—a move that raises a credibility question: are near-term misses transient, or is guidance too optimistic?
Where margins fell short
The manufacturing EBITDA miss is material. Guidance of 5–7 per litre was reaffirmed for full-year FY27. Q2 landed at ₹4.6—below the midpoint, below the prior quarter's run-rate (H1 at ₹5.9/litre). Management cited three culprits: (1) Q2 seasonality—higher raw material and fuel costs, plus plant maintenance. (2) UP distillery contribution—The Uttar Pradesh facility is ramping volumes but carries lower per-litre margins than legacy Rajasthan assets, a deliberate trade-off for longer-term leverage. (3) FCI broken-rice availability—Lower allocation in Q2 squeezed the ability to flex toward higher-margin feedstock. The company holds that once ENA supply year 2026–27 kicks off and maize prices moderate, the mix improves.
The R&O margin decline is symptomatic. Q2 R&O EBITDA margin sat at ~16%—still inside the 15–17% guidance band, but down 160 bps from the prior year. Raw material inflation (particularly for grain) and oil-linked packing costs were the primary drivers. Rajasthan, the core market, also saw slight volume softness. Yet again, management signaled that the headwinds are temporary: once commodity prices stabilize (expected post-Diwali per commentary) and the UP overhead base dilutes with higher volumes, margins should recover.
Manufacturing EBITDA margin INR 5–7/litre FY27 guidance remains intact
Q2 at ₹4.6/litre; H1 at ₹5.9/litre
Contradicted (below band)
R&O margins expected to normalize to 15–17% (down from prior 17–18% due to UP mix)
Q2 at ~16%, down 160 bps YoY
Contradicted (not yet normalized)
P&A moved close to EBITDA breakeven
Q2 EBITDA loss ₹0.2 Cr on ₹59.9 Cr revenue
Supported (loss narrowed)
No major capex post-UP; P&A self-funded from cash generation
₹200 Cr QIP raised; ₹150 Cr used for debt paydown; balance liquid
Supported (capex minimal)
What changed on this call
P&A trajectory upgraded. The segment loss narrowed to ₹0.2 Cr in Q2 (vs. prior unprofitability), driven by 54% revenue growth to ₹59.9 Cr and 64% volume growth to 0.46M cases. H1 EBITDA loss neared zero. Five of twelve states are already profitable; seven are being funded from those five. Management is confident the segment reaches breakeven by H2 FY27.
UP expansion pace reset downward. The Uttar Pradesh distillery is currently running at ~85% capacity utilization. Management flagged this explicitly; full production has not materialized. Margins are structurally 100–200 basis points lower than Rajasthan's mix due to maize-based (lower value-add) feedstock. The ramp is on track, but full upside is deferred.
OMC ethanol order delays. The company has not completed all government offtakes from Oil Marketing Companies. Expected completion is ~30 November 2026. Secondary allocations are pending; timelines add execution risk. Once completed, significant volume lift and improved utilization are expected.
QIP deployed for debt paydown. The company raised ₹200 Cr through qualified institutional placement. ₹150 Cr went to debt repayment (improving debt/EBITDA to ~2.0x from 2.63x). The balance is earmarked for IMFL expansion and working capital. No large new distillery capex was flagged.
The bull-bear ledger
Revenue growth solid at +15% YoY; volumes up 55–64% across segments
P&A inflecting: loss narrowed sharply; path to profitability visible
Debt/EBITDA improved to ~2.0x post-QIP; balance sheet de-risked
Long-term optionality: UP scale, state proliferation (7–8 from 4–5), ENA/maize flex, CSG entry
Manufacturing EBITDA at ₹4.6/litre; well below 5–7 mid-point guidance
R&O margins down 160 bps YoY; not yet back to prior levels
P&A still unprofitable; breakeven timeline uncertain beyond H2 FY27
Rajasthan concentration risk: ~34% of revenue; state board allocation limits share growth
Commodity headwinds unresolved; no hedging mentioned; guidance dependent on stabilization
OMC order completion delayed to November; execution risk persists
Risks, ranked by how much they should concern a holder
Margin guidance credibility
HighManufacturing EBITDA missed guidance on both Q2 and H1 basis. R&O margins down 160 bps YoY, not yet recovered. If Q3/H2 doesn't show recovery, guidance loses credibility.
Management cited temporary factors (seasonality, commodity volatility, UP ramp). ENA supply year clarity and commodity moderation expected to trigger recovery. Track Q3/H2 per-litre and margin trends closely.
Commodity price leverage
HighRaw material (FCI rice broken-content, maize prices, grain costs) directly levers EBITDA. R&O margin compressed 160 bps primarily by RM inflation. No hedging program mentioned. Oil prices impact packing cost.
Feedstock flexibility (ENA vs. maize vs. broken rice) provides partial buffer. Management claims 80–85% capacity utilization absorbs cost swings. But timing and magnitude of cost recovery remain uncertain.
UP expansion execution
MediumUP currently at ~85% utilization, not full production. Margins structurally 100–200 bps lower than Rajasthan due to maize-based mix. Full margin accretion deferred. If utilization plateaus, margin recovery stalls.
OMC orders (completion expected Nov 2026) and ENA supply year expected to drive utilization higher. Policy shift (maize over molasses) is structural tailwind. But ramp pace remains unpredictable.
P&A profitability delays
MediumSegment still unprofitable (loss ₹0.2 Cr in Q2). Breakeven target H2 FY27, but if volumes plateau or A&P spend doesn't pay off, timeline slips. Cost absorption at risk.
Volume growth strong (54–64% YoY). Five of twelve states already profitable; organic scale should absorb P&A costs. But expansion into 7 loss-making states is expensive.
Rajasthan market concentration
MediumR&O (40% of revenue) heavily weighted to Rajasthan. State reserves 40% of market for public sector; Globus has ~50% of remaining private share. Limited headroom for organic growth in Rajasthan.
UP and state proliferation (7–8 states vs. current 4–5) de-risk concentration. But execution takes time; near-term revenue leverage is Rajasthan-capped.
CSG entry and competitive pressure
LowCompeting spirits brands entering via CSG (duty-free) channels in Q3 FY27. Risk of price pressure and brand switching. DWAAR (Globus's new blended whiskey) in early pilot.
Globus has established brand presence and distribution. New entrants face switching costs and distribution hurdles. Management downplayed risk; argues brand loyalty is sticky.
OMC tender delays
LowEthanol orders not yet completed; expected ~30 November 2026. Secondary allocations add timing uncertainty. If further delayed, utilization target and ethanol revenue miss.
Long-term offtake agreements with OMCs provide floor. Multiple distilleries across states allow flexibility. Completion by November is critical for H2 momentum.
How the street is positioned
The equity market has already rendered its verdict. The stock is at ₹699 as of 5 November 2026—a 60.3% decline from its all-time high of ₹1,759.50. It trades below all major moving averages (SMA 20 at ₹743, SMA 50 at ₹809, SMA 200 at ₹889), signaling a sustained downtrend. The RSI sits at 37.7, indicating neutral oversold conditions but not yet at capitulation lows. Volume is normal; there's no panic liquidation, but there's also no accumulation.
Ownership has been flat to slightly negative. FII holdings ticked down 7 basis points quarter-on-quarter to 7.46%; DII reduced holdings by 37 basis points to 10.56%. Promoters held steady at 50.56%. The absence of fresh institutional support despite a deep drawdown suggests the street remains skeptical of near-term execution. No bulk or block deals flagged.
The price action and ownership pattern are consistent with the fundamental story: a company with long-term optionality (UP, state expansion, ENA leverage) but near-term execution risk (margin misses, commodity headwinds, P&A profitability delays). The 60% drawdown from ATH prices in capitulation, but the lack of positive fund flows or insider accumulation suggests the street is waiting for proof of margin recovery before re-engagement.
The debate
What to watch next
1 · November 2026: OMC ethanol order completion + ENA supply year kickoff
Expected completion of OMC offtakes by ~30 November 2026 and start of new ENA (ethanol from agriculture) supply year. These are the two key catalysts for ethanol segment volume uptake and utilization improvement. If delayed or missed, execution credibility erodes further.
2 · H2 FY27 (Oct–March 2027): Manufacturing EBITDA per-litre recovery and R&O margin stabilization
The test of management's guidance. Will manufacturing EBITDA return to at least ₹5 per litre? Will R&O margins stabilize back to 15–17%? These two metrics are the heart of the margin recovery thesis. Q3 earnings (late Jan/early Feb) will be the first hard data point.
3 · Q3 FY27 / H2 FY27: P&A segment breakeven and new state contribution
Will P&A actually achieve EBITDA breakeven by H2 FY27 as promised? Will the 7 loss-making states show margin traction? Also watch for CSG entry execution (targeting Q3, subject to approvals). DWAAR launch impact in pilot markets.
4 · Commodity price index (ongoing): FCI broken rice allocation, maize prices, oil/packing costs
Management's entire margin recovery thesis depends on commodity stabilization post-Diwali. Track FCI rice broken-content allocation, maize futures, and crude/bunker oil trends. If any of these tick higher again, margin guidance credibility takes another hit.
The verdict
Globus Spirits delivered solid revenue growth in Q2—but margin execution is the real story, and it's disappointing. The company is running both its manufacturing and R&O segments below guidance, citing temporary factors (seasonality, commodity volatility, UP ramp). Management reaffirmed guidance, signaling confidence in recovery. But confidence alone doesn't move the stock; proof does. The next two quarters will show whether the near-term misses are transient or structural.
The long-term case is intact: UP distillery, state proliferation, ENA leverage, and CSG entry offer genuine optionality. But near-term execution risk is material and unresolved. At ₹699, the stock is down 60% from ATH—a level that prices in significant downside but also leaves room for re-engagement once margin recovery is demonstrated.
Hold is the honest read. The stock's trajectory hinges on one number: will manufacturing EBITDA return to at least ₹5 per litre by H2? If yes, guidance holds and the stock finds support. If no, credibility erodes and downside extends. Commodity price trajectory and OMC order completion by November are the near-term catalysts. Track Q3 earnings (due late Jan/early Feb 2027) closely. Until then, the debate is unresolved.
Informational and educational content only. Not investment advice.